Quality of Anticoagulation With Warfarin in Patient With Atrial Fibrillation for Secondary Stroke Prevention in Korea

Factors Associated to the Instability of the INR (International Normalized Ratio ) in the Prevention of Thromboembolism AVK (Anti Vitamin K) in Atrial Fibrillation in the Elderly: Instead of Comorbidities

NCT02841475 ·Status: COMPLETED

The Association Between Non-vitamin K Antagonist Oral Anticoagulant Therapy and Acute Stroke Severity and Post Stroke Short-term and Long-term Outcomes.

NCT05283174 ·Status: RECRUITING

Warfarin - How Good Are we at Maintaining Target Range ?

NCT01081327 ·Status: COMPLETED

Subtherapeutic INR Levels in Patients With AVK: Incidence, Associated Factors, Prognosis and Control Strategies

NCT02610153 ·Status: COMPLETED

D-dimer In Patients With atRial Fibrillation rEceiving antiCoagulation Therapy

NCT03280641 ·Status: COMPLETED

Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over

NCT02286414 ·Status: COMPLETED

Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 75 Years and Over Suffering From Non Valvular Atrial Fibrillation (nv AF)

NCT02906527 ·Status: UNKNOWN

Monitor System for the Safety of Dabigatran Treatment

NCT02414035 ·Status: COMPLETED

The Pharmacogenetics of Optimal Warfarin Therapy in Chinese Patients After Heart Valve Replacement.

NCT02710747 ·Status: UNKNOWN ·Phase: PHASE4

An Observational Cross-sectional Study Evaluating the Sociodemographic and Clinical Characteristics of Patients Diagnosed With NVAF With a Risk of Stroke or Systemic Embolism, Who Are on Treatment to Adequately Control Their Coagulation and Treated in Primary Care Centres

NCT02470767 ·Status: COMPLETED

An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers

NCT02559232 ·Status: COMPLETED

Association Between Genetic Variant Scores and Warfarin Effect

NCT03894878 ·Status: COMPLETED

Early Versus Late Resumption of Anticoagulation in Patients With Both High Thrombosis Risk and Major HEmoRrhage

NCT02091479 ·Status: TERMINATED ·Phase: PHASE3

Pleotropic Effect of New Oral Anticoagulants

NCT02544932 ·Status: UNKNOWN ·Phase: PHASE3

Assessment of International Normalized Ratio (INR) Prolongation in Patients Treated Simultaneously With Warfarin and Cephalosporins

NCT01857050 ·Status: COMPLETED

Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection

NCT02247414 ·Status: COMPLETED ·Phase: PHASE4

Rivaroxaban Estimation With Warfarin in Atrial Fibrillation Patients With Coronary Stent Implantation Study (REWRAPS)

NCT02024230 ·Status: COMPLETED ·Phase: PHASE4

Comparative Effectiveness and Safety Between Warfarin and Dabigatran

NCT03254134 ·Status: COMPLETED

The Efficacy and Safety of Non-vItamiN K antaGonist oraL Anticoagulants for intermEdiate Stroke Risk in Patients With Atrial Fibrillation (SINGLE-AF)

NCT04437654 ·Status: RECRUITING ·Phase: PHASE4

Safety and Efficacy of Edoxaban in Thoracoscopic Ablation

NCT04121767 ·Status: COMPLETED ·Phase: NA

DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation

NCT00806624 ·Status: COMPLETED ·Phase: PHASE2

Length of Stay in NVAF Patients Hospitalized and Initiated With Dabigatran or Warfarin in Japan

NCT02631057 ·Status: COMPLETED

Non-Interventional Study on Effectiveness of Elxaban Tab. in Patients With Non-valvular Atrial Fibrillation

NCT04125641 ·Status: UNKNOWN

Excessive Warfarin Anticoagulation - Causes and Consequences

NCT02761941 ·Status: UNKNOWN

The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT

NCT02376803 ·Status: COMPLETED ·Phase: PHASE4